Drug Patent Expirations for Feb 9, 2017

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them

Click the patents below for more details, or visit DrugPatentWatch.com for more options.

AZILECT (rasagiline mesylate)
Teva
Patent number:5,453,446
Expiration Date:Feb 7, 2017

ELOXATIN (oxaliplatin)
Sanofi Aventis Us
Patent number:5,420,319
Expiration Date:Feb 9, 2017

KYNAMRO (mipomersen sodium)
Kastle Theraps Llc
Patent number:6,451,991
Expiration Date:Feb 11, 2017

DrugPatentWatch provides instant access to actionable insights on pharmaceutical drugs.

For more information try a trial


   One Comment


  1. antibody discovery
      February 14, 2017

    Our team are currently working on antibody discovery. We do need to know more info about these Expirations.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: